INTEGRATED BIOPHARMA INC (INBP) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US45811V1052

Price
0.17 USD
Market cap
5.28 m USD
P/E (2026)
–
P/S (2026)
0.12
Dividend yield
0.00 %
Net margin
-6.48 %
Return on equity (ROE)
-16.09 %
Return on assets (ROA)
-11.22 %

INTEGRATED BIOPHARMA INC financials

Fiscal year20252026
Revenue54.35 m USD43.87 m USD
Gross profit5.56 m USD800,000.00 USD
Operating income2.02 m USD-2.71 m USD
EBIT2.11 m USD-2.55 m USD
Net income808,000.00 USD-2.84 m USD
Diluted EPS – continuing operations0.03 USD-0.09 USD

Full history since 2000, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About INTEGRATED BIOPHARMA INC

Integrated BioPharma, Inc., together with its subsidiaries, engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. The company operates through two segments, Contract Manufacturing and Other Business Lines. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment provides warehousing and fulfilment services; and distributes raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.